INNOVHEM is part of the 4th promotion of SISTA Entrepreneures with AXA FRANCE. This program aims to support the financing of companies run by women.
Aventure France 2030 ! 🏆 Hier, à Paris, se tenait le Comité interministériel de l'innovation C2i. Nous sommes fiers de faire partie de...
Another step forward in the fight against sickle cell disease ! On the occasion of the state visit to France by Their Majesties King Frederik X and...
Innovhem to present New data on single-cell quantification of HbF and HbS at the 2024 ASH Annual Meeting. One poster presentation to feature new...
Innovhem's patents protect our BIOMARKERS : An important news ! SINGLE CELL QUANTIFICATION OF FETAL HEMOGLOBIN patent has been issued in France,...
HEMOPROVE is an Open-label One Stage Phase II study sponsored by AP-HP. The investigator hypothesis is that the treatment by Voxelotor (GBT440) will...
Innovhem is proud to be part of the first promotion of the french accelerator for digital health prevention ! BPI France and PariSanté Campus have...